Sales and Marketing

Showing 15 posts of 11527 posts found.

Google X developing diagnosis pill

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing AbbVie, Pfizer, calico, diagnosis pill, google, google x, vida, wearables

Google is developing a new pill designed to send microscopic particles into the bloodstream in an effort to identify cancers, …

Cancer Drugs Fund ‘papering over the cracks of a bigger issue’

October 29, 2014 Medical Communications, Research and Development, Sales and Marketing Cancer, Kadcyla, NICE, breast cancer, reform

Breakthrough Breast Cancer has raised concerns to the government this week over the ever-increasing price of new oncology medicines. Over …

Quantum promotes senior head

October 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alison Doering, quantam pharmaceutical

Alison Doering has been promoted to head of group marketing and communications at medicines manufacturing firm Quantum Pharmaceutical.  Doering will …

Merck revenue falls

October 28, 2014 Manufacturing and Production, Sales and Marketing Frazier, Merck, Q3, Victrelis, hep C, sovaldi

Merck has posted a set of disappointing financials for the latest quarter as it cuts cost across its business to …

Karus Therapeutics appoints two heads

October 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Peter Finan, Simon Roitt, karus

UK drug development firm Karus Therapeutics has grown its R&D team via two new appointments in Dr Simon Roitt, who …

Celgene expands immunotherapy pipeline with Sutro

October 27, 2014 Research and Development, Sales and Marketing Celgene, PD-1 and PD-L1, Q3, oncology, sutro

Celgene has extended its collaboration with Sutro Biopharma and added a buyout option for the firm as the two companies …

AZ oncology drug a ‘Phoenix from the flames’

October 27, 2014 Sales and Marketing AstraZeneca, CHMP, EC, lynparza, olaparib, oncology

As the possibility of a deal with Pfizer fades, AstraZeneca is continuing its argument for independence as a key cancer …

Scenesse recommended for rare sun disease in Europe

October 27, 2014 Sales and Marketing CHMP, Clinuvel Pharmaceuticals, EMA, EU, scenesse

The European Medicines Agency is recommending that Scenesse (afamelanotide) be approved for the prevention of severe sun burn in adults …

France Focus: Power without responsibility?

October 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing France, Lantus, Sanofi, Servier, hollande, perindopril, report

Population: 65.8 million (2013) Government: Unitary semi-presidential constitutional republic Leader: François Hollande of the centre-left Socialist Party Gross Domestic Product: …

Cubist Pharmaceuticals names chief executive

October 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cubist, perez

US biopharma firm Cubist Pharmaceuticals has named Robert Perez as its chief executive and who will begin the role from …

Cancer drug discovery system ‘broken’

October 24, 2014 Research and Development, Sales and Marketing Cancer, cancer research, oncology, paul workman

The global system for discovering new cancer drugs is ‘broken’ and failing to turn scientific advances into enough innovative new …

Lacklustre sales hit Lilly again

October 24, 2014 Sales and Marketing Q3, cymbalta, humilin, lilly, sales, zyprexa

Lilly is enduring one of the bleakest financial years in its history as patent expiries continue to take chunks out …

Innovation director appointed to NHS England

October 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NHS England, tony young

NHS England has hired a new national clinical director for innovation in Professor Tony Young. Young’s role will be to …

UK government and partners pay £230m for disease research

October 23, 2014 Research and Development, Sales and Marketing Arthritis Research UK, British Heart Foundation, Cancer Research UK, London, MRC, Osborne, UK, Wellcome Trust, dementia, research

A new partnership led by the Medical Research Council and the UK government will invest over £230 million in a …

GSK mulls $27 billion ViiV sell-off

October 23, 2014 Medical Communications, Sales and Marketing AIDS, Advair, GSK, HIV, Pfizer, Q3, Shionogi, Tivicay, ViiV

After a difficult few years and another poor quarter, GlaxoSmithKline has announced that it is looking to float its fast-growing …
The Gateway to Local Adoption Series

Latest content